|
End-of-day quote
Bulgaria S.E.
2026-08-25
|
5-day change | 1st Jan Change | ||
| 2.080 EUR | 0.00% |
|
+7.77% | +46.01% |
| 07-22 | Sopharma AD Reports Sales Results for the First Half 2026 | CI |
| 06-29 | Sopharma AD Approves Gross Dividend for 2025 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Drug Retailers
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1.28B | - | - | - | - | - |
| 15.44B | |||||
| 6.6B | |||||
| 6.42B | |||||
| 4.29B | |||||
| 3.25B |
- Stock Market
- Stocks
- SFA Stock
- Charts Sopharma AD
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
